SCHEMBL12846932

SCHEMBL12846932

CCN(C)c1ccc2nc(C)n(C(c3ccccc3)c3ccccc3)c(=O)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.39
▸ NTSR1 P30989 2/20 0.39
▸ IP6K1 Q92551 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ IGLV6-57 P01721 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.35
▸ HPGD P15428 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ IDO1 P14902 1/20 0.34
▸ TDO2 P48775 1/20 0.34
▸ IDO2 Q6ZQW0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788906 0.91 NTSR1 (0.40) DHFRNTSR1IP6K1ALDH1A1MAPK1
SCHEMBL13564458 0.90 DHFR (0.39) DHFRIP6K1ALDH1A1MAPK1RAB9A
SCHEMBL12788409 0.89 CASR (0.40) DHFRALDH1A1MAPK1RAB9AKDM4E
SCHEMBL12788421 0.89 IP6K1 (0.50) DHFRIP6K1MEN1KMT2A
SCHEMBL12788332 0.88 PDE3B (0.46) DHFRIP6K1ALDH1A1MAPK1RAB9A
SCHEMBL12788592 0.87 DHFR (0.37) DHFRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12788508 0.87 DHFR (0.41) DHFRIP6K1ALDH1A1MAPK1RAB9A
SCHEMBL12788890 0.87 DHFR (0.55) DHFRIP6K1ALDH1A1MAPK1RAB9A
SCHEMBL12788878 0.87 ALDH1A1 (0.37) DHFRIP6K1ALDH1A1MAPK1RAB9A
SCHEMBL12788886 0.87 NAMPT (0.38) DHFRIP6K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297117-B1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME (US) 2012-10-31 — — EP disclosed
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME CORP. 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS GPR119, GPR39, GPR65 DHFR 3231/4885NTSR1 107/4885IP6K1 2314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback